Among these, ABCC3, ACPP, PPP1CA, PRKAG3, and RNASEL exhibited interactions with several proteins, immune checkpoint markers, and chemotherapeutic drugs administered in both human breast cancer and FMC (Fig 5). The gene discussed is RNASEL; the disease is breast carcinoma.